Systems and methods for cleaning a hard-coated ophthalmic lens and stripping the hard-coating of the hard coated ophthalmic lens in a single pass process are disclosed. The hard-coated ophthalmic lens is sequentially treated with a cleaning solution, an alkaline solution, and a stripping solution. Ultrasonic power is applied to the solutions and the ophthalmic lens during the process. The resulted ophthalmic lens has substantially no sign of chemical attack or residual hard coating or varnishes thereon.

The present invention recognizes that medical devices, such as but not limited to contact lenses, can be made having a coating made at least in part using printing technologies to provide drug storage and drug release structures. The coating preferably includes at least one drug reservoir layer and a least one barrier layer, and can include structures, such as but not limited to capillary structures, which alone or in combination modulate the release of the drug from the coating. One aspect of the present invention is a medical device that incorporates a drug in at least one coating. A second aspect of the present invention is a method of making a medical device that incorporates a drug in at least one coating. A third aspect of the present invention is a method of using a medical device of the present invention to treat or prevent a disease, disorder or condition.

A contact lens package includes a silicone hydrogel contact lens, a packaging container composed of a polypropylene, and a packaging solution containing a nonionic surfactant, the nonionic surfactant including a linear alkyl moiety having 12 or more carbon atoms and an oxyethylene moiety, the average addition mole number of oxyethylene being 30 or more per mole of the nonionic surfactant.

A contact lens package includes a silicone hydrogel contact lens, a packaging container composed of a polypropylene, and a packaging solution containing a nonionic surfactant, the nonionic surfactant including a linear alkyl moiety having 12 or more carbon atoms and an oxyethylene moiety, the average addition mole number of oxyethylene being 30 or more per mole of the nonionic surfactant.

The present invention recognizes that medical devices, such as but not limited to contact lenses, can be made having a coating made at least in part using printing technologies to provide drug storage and drug release structures. The coating preferably includes at least one drug reservoir layer and a least one barrier layer, and can include structures, such as but not limited to capillary structures, which alone or in combination modulate the release of the drug from the coating. One aspect of the present invention is a medical device that incorporates a drug in at least one coating. A second aspect of the present invention is a method of making a medical device that incorporates a drug in at least one coating. A third aspect of the present invention is a method of using a medical device of the present invention to treat or prevent a disease, disorder or condition.

Process for treating solid waste containing an organic fraction, comprising an initial step of extrusion pressing the waste with production of a solid fraction and a liquor. The solid fraction is subjected to a milling treatment at a pressure lower than the atmospheric pressure in a rotary mill that produces a sanitized dry solid and water. The liquor is subjected to a treatment of anaerobic digestion in three subsequent steps, with production of biogas and of a digestate that is subjected to evaporation under vacuum to obtain a concentrated compost and steam, re-used in other steps of the process. The sanitized dry solid and the biogas can be used as fuel to produce thermal and electric energy to be used in the process, which also allows surplus energy to be obtained.

Process for treating solid waste containing an organic fraction, comprising an initial step of extrusion pressing the waste with production of a solid fraction and a liquor. The solid fraction is subjected to a milling treatment at a pressure lower than the atmospheric pressure in a rotary mill that produces a sanitized dry solid and water. The liquor is subjected to a treatment of anaerobic digestion in three subsequent steps, with production of biogas and of a digestate that is subjected to evaporation under vacuum to obtain a concentrated compost and steam, re-used in other steps of the process. The sanitized dry solid and the biogas can be used as fuel to produce thermal and electric energy to be used in the process, which also allows surplus energy to be obtained.

The present invention recognizes that medical devices, such as but not limited to contact lenses, can be made having a coating made at least in part using printing technologies to provide drug storage and drug release structures. The coating preferably includes at least one drug reservoir layer and a least one barrier layer, and can include structures, such as but not limited to capillary structures, which alone or in combination modulate the release of the drug from the coating. One aspect of the present invention is a medical device that incorporates a drug in at least one coating. A second aspect of the present invention is a method of making a medical device that incorporates a drug in at least one coating. A third aspect of the present invention is a method of using a medical device of the present invention to treat or prevent a disease, disorder or condition.

The present invention recognizes that medical devices, such as but not limited to contact lenses, can be made having a coating made at least in part using printing technologies to provide drug storage and drug release structures. The coating preferably includes at least one drug reservoir layer and a least one barrier layer, and can include structures, such as but not limited to capillary structures, which alone or in combination modulate the release of the drug from the coating. One aspect of the present invention is a medical device that incorporates a drug in at least one coating. A second aspect of the present invention is a method of making a medical device that incorporates a drug in at least one coating. A third aspect of the present invention is a method of using a medical device of the present invention to treat or prevent a disease, disorder or condition.

Systems and methods for recharging zirconium phosphate and zirconium oxide are provided. The systems and methods provide for recharging of the zirconium phosphate and zirconium oxide in reusable sorbent modules. The systems and methods include recharging flow paths for recharging zirconium phosphate independently or concurrently.